Delivery Order SPE2DB24D1104-SPE2DB25FYFP0
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) under a firm fixed price contract valued at $2,280.66. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $6,382.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (quantity of 7 units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's corporate office, with performance occurring at the company's Conshohocken, Pennsylvania location. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets, a medication used to treat endometriosis. The award has a ceiling value of $3,100.78 and a completion date of June 26, 2025. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4569155062, Orilissa 150 mg tablets (quantity 7), valued at $10,086.63 under a firm fixed price contract type. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. No set-aside designation was used for this competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,651.12 firm fixed-price delivery order is for the drug Orilissa 150 mg tablet, with a completion date of May 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,600.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets, a medication used in the treatment of endometriosis, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,059.98 firm-fixed-price contract is for the delivery of Orilissa 150 mg tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...